JOHNSON & JOHNSON - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 72 filers reported holding VOR BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
JOHNSON & JOHNSON ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q2 2024$1,074,658
-57.8%
1,074,6580.0%0.27%
+362.1%
Q1 2024$2,546,939
+5.3%
1,074,6580.0%0.06%
+5.5%
Q4 2023$2,417,981
+6.1%
1,074,6580.0%0.06%
-93.4%
Q3 2023$2,278,275
-31.4%
1,074,6580.0%0.84%
-18.6%
Q2 2023$3,320,693
-42.6%
1,074,6580.0%1.03%
-45.2%
Q1 2023$5,781,660
+80807.6%
1,074,6580.0%1.88%
-9.5%
Q4 2022$7,146
-99.8%
1,074,6580.0%2.08%
+65.1%
Q3 2022$4,277,000
-19.9%
1,074,6580.0%1.26%
-7.7%
Q2 2022$5,341,000
-17.7%
1,074,6580.0%1.36%
+11.2%
Q1 2022$6,491,000
-48.0%
1,074,6580.0%1.23%
-13.7%
Q4 2021$12,488,000
-25.9%
1,074,6580.0%1.42%
-3.8%
Q3 2021$16,851,0001,074,6581.48%
Other shareholders
VOR BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,692,429$124,814,00031.41%
Trustees of Columbia University in the City of New York 183,821$3,428,0005.06%
RA Capital Management 11,120,973$207,406,0003.33%
Johnson & Johnson Innovation - JJDC, Inc. 1,074,658$20,042,0002.05%
Sarissa Capital Management LP 707,010$13,186,0001.05%
SECTORAL ASSET MANAGEMENT INC 405,324$7,559,0000.61%
Woodline Partners LP 1,146,494$21,382,0000.40%
Artal Group S.A. 550,000$10,258,0000.21%
NEXPOINT ASSET MANAGEMENT, L.P. 50,000$933,0000.20%
Orbimed Advisors 833,333$15,542,0000.16%
View complete list of VOR BIOPHARMA INC shareholders